Home

Insights

Torrent Pharmaceuticals Ltd P/E Ratio

Torrent Pharmaceuticals Ltd P/E Ratio

download
stocks purchased

₹ 0.7 Cr

Volume transacted

stocks purchased

2.5 K

stocks traded

Image

Torrent Pharmaceuticals Ltd

NSE: TORNTPHARM

PE

62.2

Last updated : 23 May 15:30 pm

Key Highlights

    The P/E Ratio of Torrent Pharmaceuticals Ltd is 62.2 as of 23 May 15:30 pm .a1#The P/E Ratio of Torrent Pharmaceuticals Ltd changed from 75.7 on March 2019 to 41.8 on March 2023 . This represents a CAGR of -11.20% over 5 years. a1#The Latest Trading Price of Torrent Pharmaceuticals Ltd is ₹ 2691 as of 23 May 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.7 to 27.7 in 5 years. This represents a CAGR of -0.71%a1# The PE Ratio of Automobile industry is 27.2. The PE Ratio of Finance industry is 13.6. The PE Ratio of IT - Software industry is 27.9. The PE Ratio of Pharmaceuticals industry is 27.7. The PE Ratio of Retail industry is 153.5. The PE Ratio of Textiles industry is 21.1. In 2023a1#The Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 33035 crore on March 2019 to ₹ 52030 crore on March 2023 . This represents a CAGR of 9.51% over 5 years. a1#The Revenue of Torrent Pharmaceuticals Ltd changed from ₹ 2377 crore to ₹ 2787 crore over 7 quarters. This represents a CAGR of 9.52% a1#The EBITDA of Torrent Pharmaceuticals Ltd changed from ₹ 742 crore to ₹ 924 crore over 7 quarters. This represents a CAGR of 13.35% a1#The Net Profit of Torrent Pharmaceuticals Ltd changed from ₹ 354 crore to ₹ 443 crore over 7 quarters. This represents a CAGR of 13.67% a1#The Dividend Payout of Torrent Pharmaceuticals Ltd changed from 38.6 % on March 2019 to 70.82 % on March 2023 . This represents a CAGR of 12.91% over 5 years. a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

×

P/E Ratio Over Time

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

P/E Ratio Over Time

Period
Mar '1975.7
Mar '2032.6
Mar '2134.3
Mar '2260.9
Mar '2341.8

Fundamental Metrics

Market Cap

90,276 Cr

EPS

42.3

P/E Ratio (TTM) *

62.2

P/B Ratio (TTM) *

13.3

Day’s High

2695.85

Day’s Low

2660.5

DTE *

0.7

ROE *

20.0

52 Week High

2782.0

52 Week Low

1665.1

ROCE *

20.9

* All values are consolidated

* All values are consolidated

Image

Torrent Pharmaceuticals Ltd

NSE: TORNTPHARM

PRICE

2691.8

24.30(0.91%)

stock direction

Last updated : 23 May 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Torrent Pharmaceuticals Ltd

Strength

2

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Torrent Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value

Market Value

89,012

Asset Value

6,603

12.5 X

Value addition

* All values are in Rupees

PE Ratio Over Market Cap

Key Valuation Metric

Earnings

1,494 Cr

62.2 X

PE Ratio

Market Cap

₹89012Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio

PS Ratio

PB Ratio

Earnings

1,494 Cr

62.2 X

PE Ratio

Market Cap

₹89012Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Torrent Pharmaceuticals Ltd PE Ratio Calculation

  • The Price-to-Earnings (PE) ratio, also known as the P/E Ratio, is a fundamental financial metric used to assess the valuation of a company's stock in relation to its earnings performance. For Torrent Pharmaceuticals Ltd, the PE Ratio is calculated as follows:

P/E Ratio

=

Market Capitalization

Net Income

  • Given the current market conditions, Torrent Pharmaceuticals Ltd's Share Price stands at 2691.8. The Earnings per Share (Diluted) for the trailing twelve months (TTM) ending in 2024-05-23T00:00:00 is 42.32. Substituting the values into the formula, PE Ratio becomes as follows: PE Ratio = 2691.8/ 42.32= 62.15.

P/E Ratio

=

Stock Price

Earning Per Share

  • This indicates that Torrent Pharmaceuticals Ltd's stock is trading at approximately 62.15 times its earnings per share for the trailing twelve months. Alternatively, the PE Ratio can also be computed using the company's overall financial performance: PE Ratio = Market Cap / Net Income. Where Market Cap represents the total market capitalization of the company, and Net Income signifies the total earnings after expenses and taxes.

Understanding Torrent Pharmaceuticals Ltd’s PE Ratio (BSE: TORNTPHARM)

    The Price-to-Earnings (PE) ratio, used to assess Torrent Pharmaceuticals Ltd's stock (BSE: TORNTPHARM), indicates how many years it would take for the company to earn back the stock price. If a company earns ₹2 per share annually and its stock trades at ₹30, the PE ratio is 15, signifying a 15-year payback period assuming steady earnings. Earnings fluctuate, affecting the payback period, Growing earnings shorten the recovery time while declining earnings extend it. Shareholders favor shorter payback periods, preferring lower PE stocks. Among stocks with the same PE ratio, faster-growing businesses are preferred. A company with losses makes the PE ratio meaningless. Peter Lynch introduced the PEG ratio to compare stocks with different growth rates, dividing the PE ratio by the growth rate. A company is considered fairly valued when its PE ratio matches its growth rate. The PE ratio, applicable across industries, measures stock valuation based on earnings power. It indicates how quickly an investment can be recouped. Unlike the PB ratio, which assesses valuation based on the balance sheet, the PE ratio focuses on earnings. Overall, the PE ratio provides insights into stock valuation, aligning with investors' preference for faster returns.

×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '1933035
Mar '2033362
Mar '2143002
Mar '2247319
Mar '2352031

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '222377
Sep '222307
Dec '222481
Mar '222500
Jun '232625
Sep '232686
Dec '232787

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '22742
Sep '22695
Dec '22714
Mar '22736
Jun '23825
Sep '23851
Dec '23924

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '22354
Sep '22312
Dec '22292
Mar '22287
Jun '23378
Sep '23386
Dec '23443

* All values are a in crore

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '1939
Mar '2058
Mar '2152
Mar '2282
Mar '2371

* All values are a in %

About Torrent Pharmaceuticals Ltd

About Torrent Pharmaceuticals Ltd

    Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is one of the leading pharmaceutical companies having presence in Indian and global markets. Also, the company incorporated a subsidiary in Mexico, named Laboratorios Torrent SA de CV, as a first step for entry into the lucrative Mexican market. During the year 2008-09, the company made an investment of Rs 2.05 crore in the equity shares of their wholly owned subsidiary Laboratories Torrent, SA De CV, in Mexico. During the year under review, the company entered into license and supply agreement with AstraZeneca for marketing its products in international market. During the year under review, Torrent Pharmaceuticals commissioned a subsidiary in United Kingdom and Romania. In 2013, Torrent Pharmaceuticals entered into a licensing agreement with Reliance Life Sciences for three biosimilars - Rituximab, Adalimumab, and Cetuximab. In 2014, Torrent Pharmaceuticals acquired Elder Pharma's identified Indian branded formulation business in India and Nepal. During the year under review, the company launched Nephro, a dedicated division to cater to the Nephrology segment. In 2018, Torrent Pharmaceuticals acquired US based Bio-Pharm, Inc. (BPI) which includes US FDA registered manufacturing facility. Accordingly, Curatio Health Care (I) Private Limited (CHPL) was amalgamated with the Parent Company effective from 14th October, 2022, the Appointed Date.

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharmaceuticals Ltd soars 1.47%, gains for fifth straight session

Torrent Pharmaceuticals Ltd is up for a fifth straight session today. The stock is quoting...

Read more

16 May 2024 13:00

News

Torrent Pharmaceuticals to announce Quarterly Result

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 24...

Read more

11 May 2024 11:06

News

Torrent Pharmaceuticals Ltd soars 0.69%, up for fifth straight session

Torrent Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quotin...

Read more

26 Apr 2024 13:00

News

Torrent Pharmaceuticals Ltd gains for third consecutive session

Torrent Pharmaceuticals Ltd gained for a third straight session today. The stock is quotin...

Read more

24 Apr 2024 13:05

News

Torrent Pharmaceuticals Ltd spurts 0.14%, rises for fifth straight session

Torrent Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quotin...

Read more

27 Mar 2024 13:00

News

Torrent Pharma Gujarat facility clears USFDA inspection

The US Food & Drug Administration (USFDA) conducted a pre-approval inspection at Torrent P...

Read more

06 Mar 2024 11:16

Product Composition by Percentage (Revenue)

Document

Annual Reports

Annual Report 2023

dropdown
download

Credit Ratings

Credit Report 2022

dropdown
download

Concalls

Aug 2023

Transcript

May 2023

Transcript

Sep 2022

PPT

May 2021

Transcript

Feb 2021

Transcript

Oct 2020

Transcript

July 2020

Transcript

May 2020

Transcript

Aug 2023

Transcript

May 2023

Transcript

Sep 2022

PPT

May 2021

Transcript

Feb 2021

Transcript

Oct 2020

Transcript

July 2020

Transcript

May 2020

Transcript

FAQs for PE of Torrent Pharmaceuticals Ltd

What is Torrent Pharmaceuticals Ltd current share price?

The current market price of Torrent Pharmaceuticals Ltd as of May 23, 2024 is ₹2691.80.

Is Torrent Pharmaceuticals Ltd a good investment?

As per BlinkX Score Torrent Pharmaceuticals Ltd scores 27 in Revenue, 39 in Profitability. However it's advisable to conduct comprehensive research or seek advice from experts to evaluate whether it aligns with your investment objectives.

What are Torrent Pharmaceuticals Ltd's total net assets?

According to Torrent Pharmaceuticals Ltd's most recent financial filings, the company's net assets total ₹6602.8 Cr.

Is Torrent Pharmaceuticals Ltd making a profit or loss?

Torrent Pharmaceuticals Ltd's net Profit as of May 23, 2024 is close to ₹1,494 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199